Researchers have leveraged artificial intelligence to analyze the diverse peptides found in animal venoms such as snakes, spiders, and scorpions, uncovering new antimicrobial compounds with potent efficacy against drug-resistant bacteria. This innovative approach, highlighted in a Nature Communications publication led by César de la Fuente and others, taps into venom's evolutionary refinement to address the ongoing crisis of antimicrobial resistance. Experts emphasize the promise of venom-derived therapeutics as fast-acting and highly specific drug candidates.